Transcend Capital Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-794
Closed -$207K 719
2025
Q3
$207K Sell
794
-122
-13% -$32.1K 0.01% 652
2025
Q2
$224K Sell
916
-414
-31% -$103K 0.02% 555
2025
Q1
$352K Sell
1,330
-2,313
-63% -$626K 0.03% 440
2024
Q4
$924K Buy
3,643
+2,914
+400% +$782K 0.07% 251
2024
Q3
$231K Sell
729
-430
-37% -$153K 0.02% 542
2024
Q2
$433K Buy
+1,159
New +$391K 0.03% 390
2022
Q4
Sell
-571
Closed -$277K 507
2022
Q3
$277K Sell
571
-183
-24% -$89K 0.03% 380
2022
Q2
$353K Buy
754
+167
+28% +$74.3K 0.04% 348
2022
Q1
$255K Buy
587
+91
+18% +$38.1K 0.02% 426
2021
Q4
$230K Buy
496
+5
+1% +$2.21K 0.02% 428
2021
Q3
$229K Buy
+491
New +$208K 0.02% 425

Other funds holding HUM

Transcend Capital Advisors's HUM Position: Q4 2025 in Review

Transcend Capital Advisors sold out of Humana (HUM) in Q4 2025, closing a stake of 794 shares — an estimated $207K sold.

Transcend Capital Advisors first reported a position in HUM in Q3 2021 and held it in 11 quarters. The position peaked at $924K in Q4 2024. 863 funds tracked by Wall St. Rank hold HUM as of Q4 2025.

  • Transcend Capital Advisors reported no remaining Humana position as of Q4 2025 after selling out during the quarter.
  • Transcend Capital Advisors sold 794 Humana shares in Q4 2025, an estimated $207K.
  • Transcend Capital Advisors first reported a position in Humana in Q3 2021 and held it in 11 quarters.
  • Transcend Capital Advisors's Humana position peaked at $924K in Q4 2024.
  • 863 funds tracked by Wall St. Rank held Humana as of Q4 2025.

Based on Transcend Capital Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.